ESSA Pharma Inc. (V:EPI*CA)

Business Focus: Biotechnology & Medical Research (NEC)

Sector:  Healthcare Industry:  Biotechnology & Medical Research
 
Company Contact
Address: 999 West Broadway, Suite 720
VANCOUVER BC V5Z 1K5
Tel: N/A
Website: https://www.essapharma.com
IR: See website
<
Key People
David Ross Parkinson
President, Chief Executive Officer, Director
David Sidney Wood
Chief Financial Officer
Peter Virsik
Chief Operating Officer, Executive Vice President
Alessandra Cesano
Executive Vice President, Chief Medical Officer
   
Business Overview
ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, EPI-7386, is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). The Company is completing the initial Phase I clinical development of EPI-7386 as a monotherapy treatment for patients with metastatic castration-resistant prostate cancer (mCRPC). The Company is also developing ANITen bAsed Chimera (ANITAC) AR NTD degraders to suppress androgen biology.
Financial Overview
For the six months ended 31 March 2024, ESSA Pharma Inc revenues was not reported. Net loss increased 8% to $15M. Higher net loss reflects Foreign exchange decrease of 47% to $6K (income). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.31 to -$0.34.
Employees: 50 as of Sep 30, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $102.34M as of Mar 31, 2024
Annual revenue (TTM): $0.00M as of Mar 31, 2024
EBITDA (TTM): -$34.15M as of Mar 31, 2024
Net annual income (TTM): -$27.73M as of Mar 31, 2024
Free cash flow (TTM): -$21.42M as of Mar 31, 2024
Net Debt Last Fiscal Year: N/A
Shares outstanding: 44,362,991 as of May 13, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.